In analyzing the forecast for sold production of ozone therapy, oxygen therapy, aerosol therapy, and respiration apparatus in France, the projected growth from 2024 through 2028 shows a consistent upward trend. Starting at 1.3845 million items in 2024, production is anticipated to increase steadily, reaching 1.6932 million items by 2028. This constant rise suggests robust market demand and potentially increased adoption rates in healthcare settings. While actual figures for 2023 are unavailable, the forecast suggests a solid performance trajectory.
Future trends to watch for include technological advancements that could drive efficiency in therapies, as well as potential policy shifts affecting the healthcare sector's investment in respiratory therapies. Monitoring these dynamics will provide further insights into production and demand shifts over the forecast period.
